As per the IQVIA MAT data, pegfilgrastim 6 mg / 0.6 mL injection for subcutaneous use in a single-dose prefilled syringe had estimated annual sales of $1,295 million in the US for the 12 months ending September 2025.
As per the IQVIA MAT data, pegfilgrastim 6 mg / 0.6 mL injection for subcutaneous use in a single-dose prefilled syringe had estimated annual sales of $1,295 million in the US for the 12 months ending September 2025.